Comprehensive Financial Planning Inc. PA Takes $47,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Comprehensive Financial Planning Inc. PA acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 359 shares of the financial services provider’s stock, valued at approximately $47,000.

Several other institutional investors have also made changes to their positions in the company. Park Avenue Securities LLC bought a new position in iShares Biotechnology ETF in the third quarter worth $218,000. Valeo Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $206,000. Martin Capital Advisors LLP increased its holdings in iShares Biotechnology ETF by 1.0% in the third quarter. Martin Capital Advisors LLP now owns 13,169 shares of the financial services provider’s stock valued at $1,918,000 after purchasing an additional 133 shares during the last quarter. ORG Wealth Partners LLC bought a new position in shares of iShares Biotechnology ETF during the third quarter worth $243,000. Finally, Empirical Asset Management LLC raised its position in shares of iShares Biotechnology ETF by 2.0% during the third quarter. Empirical Asset Management LLC now owns 14,658 shares of the financial services provider’s stock worth $2,134,000 after purchasing an additional 290 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 1.1 %

IBB stock opened at $136.15 on Tuesday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The stock has a 50-day moving average price of $136.10 and a two-hundred day moving average price of $141.27.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.